Description
Michael S. Lloyd, MD, FHRS of Emory University discusses Catheter Ablation of Atrial Fibrillation in Adult Congenital Heart Disease: Procedural Characteristics and Outcomes with Natasja M. S. De Groot, MD, PhD, of Erasmus University Medical Center, and Jeremy P. Moore, MD, MS, FHRS, CCDS, CEPS-P, of UCLA Medical Center.
Learning Objectives
- Describe the differences between catheter ablation of AF in a patient with adult congenital heart disease versus those without.
- List the limitations of this study's methodology.
- Explain how the findings of this study could affect clinical practice.
Article Authors and Podcast Contributors
Article Authors
Tiffany Y. Hu, MD, Chaitra Janga, MBBS, Mustapha Amin, MD, Nicholas Y. Tan, MD, MS, David O. Hodge, MS, Ramila A. Mehta, MS, Christopher J. McLeod, MBBCh, PhD, Anca Chiriac, MD, PhD, William R. Miranda, MD, Heidi M. Connolly, MD, Samuel J. Asirvatham, MD, Abhishek J. Deshmukh, MBBS, Alexander C. Egbe, MBBS, MPCH, Malini Madhavan, MBBS
Podcast Contributors
Michael S. Lloyd, MD, FHRS, of Emory University
Natasja M. S. De Groot, MD, PhD, of Erasmus University Medical Center
Jeremy P. Moore, MD, MS, FHRS, CCDS, CEPS-P, of UCLA Medical Center
Disclosures
All relevant financial relationships have been mitigated.Host Disclosure(s):
M. Lloyd: Honoraria/Speaking/Consulting Fee: Medtronic, Baylis Medical Company, Boston Scientific
Contributor Disclosure(s):
N. De Groot: Honoraria/Speaking/Consulting Fee: Biosense Webster
J. Moore: No relevant financial relationships with ineligible companies to disclose.
Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):
J. Glenn: No relevant financial relationships with ineligible companies to disclose.
S. Sailor: No relevant financial relationships with ineligible companies to disclose.